EU regulators endorse Eli Lilly’s oral GLP-1 pill orforglipron
read at Endpoints ↗RegulatoryNeutral
The European Medicines Agency’s human medicines committee (CHMP) has given a positive opinion on Eli Lilly’s oral GLP-1 medication, orforglipron, providing the drug with EU regulatory backing.
The endorsement moves Lilly closer to market approval in Europe and is seen as an effort to compete with Novo Nordisk’s injectable GLP-1 product, Wegovy.
The CHMP decision also covered three additional new medicines, though details on those products were not disclosed in the brief report.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “CHMP endorses Eli Lilly’s GLP-1 pill and three other new drugs”
read at Endpoints ↗82 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that